These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28623459)

  • 21. Tribody [(HER2)
    Oberg HH; Kellner C; Gonnermann D; Sebens S; Bauerschlag D; Gramatzki M; Kabelitz D; Peipp M; Wesch D
    Front Immunol; 2018; 9():814. PubMed ID: 29725336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.
    Carson WE; Parihar R; Lindemann MJ; Personeni N; Dierksheide J; Meropol NJ; Baselga J; Caligiuri MA
    Eur J Immunol; 2001 Oct; 31(10):3016-25. PubMed ID: 11592078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.
    Liu S; Zhang H; Li M; Hu D; Li C; Ge B; Jin B; Fan Z
    Cell Death Differ; 2013 Mar; 20(3):456-64. PubMed ID: 23154388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.
    Jin HS; Park Y
    BMB Rep; 2021 Jan; 54(1):2-11. PubMed ID: 33298247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis.
    Bi J; Zhang Q; Liang D; Xiong L; Wei H; Sun R; Tian Z
    Hepatology; 2014 May; 59(5):1715-25. PubMed ID: 24319005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIGIT as an emerging immune checkpoint.
    Harjunpää H; Guillerey C
    Clin Exp Immunol; 2020 May; 200(2):108-119. PubMed ID: 31828774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry.
    van der Haar Àvila I; Marmol P; Cany J; Kiessling R; Pico de Coaña Y
    Methods Mol Biol; 2019; 1913():181-194. PubMed ID: 30666607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.
    Li Y; Zhang Y; Cao G; Zheng X; Sun C; Wei H; Tian Z; Xiao W; Sun R; Sun H
    J Hematol Oncol; 2021 Jun; 14(1):100. PubMed ID: 34174928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.
    Zhang Q; Bi J; Zheng X; Chen Y; Wang H; Wu W; Wang Z; Wu Q; Peng H; Wei H; Sun R; Tian Z
    Nat Immunol; 2018 Jul; 19(7):723-732. PubMed ID: 29915296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
    Zhou X; Du J; Wang H; Chen C; Jiao L; Cheng X; Zhou X; Chen S; Gou S; Zhao W; Zhai W; Chen J; Gao Y
    Cell Commun Signal; 2020 Sep; 18(1):142. PubMed ID: 32894141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay.
    van der Haar Àvila I; Marmol P; Kiessling R; Pico de Coaña Y
    Methods Mol Biol; 2019; 1913():167-179. PubMed ID: 30666606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
    Lupo KB; Matosevic S
    J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers.
    Wu L; Parton A; Lu L; Adams M; Schafer P; Bartlett JB
    Cancer Immunol Immunother; 2011 Jan; 60(1):61-73. PubMed ID: 20848094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery.
    Sturniolo I; Váróczy C; Bede ÁM; Hegedűs C; Demény MÁ; Virág L
    J Vis Exp; 2024 Apr; (206):. PubMed ID: 38738886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals.
    Wang F; Hou H; Wu S; Tang Q; Liu W; Huang M; Yin B; Huang J; Mao L; Lu Y; Sun Z
    Eur J Immunol; 2015 Oct; 45(10):2886-97. PubMed ID: 26171588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune checkpoint markers and anti-CD20-mediated NK cell activation.
    Wang Z; Weiner GJ
    J Leukoc Biol; 2021 Oct; 110(4):723-733. PubMed ID: 33615552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.